NGM120

NGM120 · NGM Biopharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NGM120, covering 2025-05-29 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia. [Phase 2]

See pricing